ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2024

Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist.

Xiaosu Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.